Přihlásit se Zaregistrujte se zdarma

Účetní hodnota akcie společnosti Medicrea International SA

Jaká je hodnota metriky Účetní hodnota akcie společnosti Medicrea International SA?

Hodnota metriky Účetní hodnota akcie společnosti Medicrea International SA je -0.01

Jaká je definice metriky Účetní hodnota akcie?

Účetní hodnota akcie (Book/Share) se rovná majetku společnosti minus závazky společnosti dělené počtem vydaných akcií.

The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.

The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.

Účetní hodnota akcie společností v sektoru Health Care sektor na LSE ve srovnání se společností Medicrea International SA

Čemu se věnuje společnost Medicrea International SA?

Medicrea International SA designs, manufactures, and distributes spinal implants in France and internationally. It offers PASS range, a polyaxial spine system; PASS LP, a thoraco-lumbar fixation system; LigaPASS, a band connector for posterior thoracolumbar fixation; PASS TULIP, a top loading posterior fixation system; PASS DEGEN for thoracic and lumbar degenerative indications; PASS OCT, an occipito-cervico-thoracic fixation system; PASS MIS, a posterior anchoring system; PASS Antérieur that offers a range of specific implants enabling surgery using an anterior approach; IMPIX C, a sterile PEEK Optima cervical interbody device; IMPIX-C+, a sterile PEEK Optima cervical interbody device that is prefilled with bone substitute; and IMPIX-MANTA, a sterile PEEK Optima cervical interbody device that is preassembled on holder/ impactor and delivers with a disposable instrumentation kit. Its implants for cervical spine also include IMPIX-MANTA +, a sterile PEEK Optima cervical interbody device, which is prefilled with synthetic bone substitutes; and GRANVIA-C, a MRI compatible ceramic cervical disc. In addition, it provides implants for the thoracic and lumbar spine, such as IMPIX-L, a sterile PEEK Optima lumbar interbody device for posterior approach; IMPIX-TLIF, a sterile PEEK Optima lumbar interbody device for transforaminal approach with a pre-assembled PEEK control lead; IMPIX-ALIF, a sterile PEEK Optima lumbar interbody device for anterior approach; STABOLT, an anatomically-shaped anterior plate; OSMOSYS, a macroporous bone substitute; IMPIX-DLIF and IMPIX-DLIF SLIM sterile PEEK Optima lumbar interbody devices for direct or oblique lateral approach; and X-JAWS, a titanium lumbar staple to secure a lateral or an anterior cage. Its implants are designed to treat scoliosis, degenerative diseases, malformations, trauma, and tumors; and used in various traditional and surgical procedures. The company was founded in 1990 and is headquartered in Rillieux-la-Pape, France.

Firmy s metrikou účetní hodnota akcie podobnou společnosti Medicrea International SA